Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01447914 · OUTCOME

Time to Next Treatment (TTNT)

Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma · Source last updated 2019-08-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEDIAN
Unit
number of months
Interval / dispersion
95% Confidence Interval
Time frame
From registration on trial to next treatment or death due to any cause, whichever comes first

What was measured

Kaplan and Meier product limit methods will be used to estimate the TTNT with 95% confidence intervals.

Groups in this outcome

Tivantinib Treatment

Oral Tivantinib 360 mg twice daily continuously for each day of every 28 day treatment cycle (taken as three tablets of 120 mg each)

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Tivantinib Treatment16

Reported measurements

Source class 1
Values in number of months · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Tivantinib Treatment4Not reported115Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        1
        upper Limit
        15
        value
        4
denoms
  1. counts
    1. group Id
      OG000
      value
      16
    units
    Participants
description
Kaplan and Meier product limit methods will be used to estimate the TTNT with 95% confidence intervals.
dispersion Type
95% Confidence Interval
groups
  1. description
    Oral Tivantinib 360 mg twice daily continuously for each day of every 28 day treatment cycle (taken as three tablets of 120 mg each)
    id
    OG000
    title
    Tivantinib Treatment
param Type
MEDIAN
reporting Status
POSTED
time Frame
From registration on trial to next treatment or death due to any cause, whichever comes first
title
Time to Next Treatment (TTNT)
type
SECONDARY
unit Of Measure
number of months

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice